Paper Details

  1. Home
  2. Paper Details

Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease.

Author: FriedeTim, GibbonsChris, PagniniFrancesco, YoungCarolyn A

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a fatal condition with no cure. Fatigue is a common and disabling symptom in ALS/MND. While there are treatments available, their effectiveness for fatigue in ALS/MND is not yet proven.
Paper Details　
Original Abstract of the Article :
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is terminal, progressive neurological condition for which there are no curative treatments. Among people with ALS/MND, fatigue is a common and debilitating symptom, which is characterised by reversible motor weakness and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494184/

データ提供：米国国立医学図書館（NLM）

Fatigue in ALS/MND: Navigating the Desert of a Debilitating Symptom

[Amyotrophic lateral sclerosis (ALS)], also known as [motor neuron disease (MND)], is a devastating neurological condition that relentlessly encroaches on the body's ability to move. This review article delves into the desert of [fatigue], a debilitating symptom that plagues many individuals living with ALS/MND. The authors explore the current landscape of [treatment options] for ALS/MND-related fatigue, highlighting the lack of established effective therapies. They discuss both pharmacological and non-pharmacological approaches, emphasizing the need for ongoing research to find more effective ways to alleviate fatigue in this challenging condition. This review serves as a valuable resource for clinicians and patients seeking to navigate the complexities of managing fatigue in ALS/MND, offering insights into current strategies and encouraging further exploration of potential solutions.

Fatigue in ALS/MND: Navigating the Desert of a Debilitating Symptom

This review highlights the need for ongoing research to find more effective treatments for fatigue in ALS/MND. While current therapies have not shown consistent effectiveness, the authors encourage further exploration of both pharmacological and non-pharmacological approaches to alleviate this debilitating symptom. This review serves as a valuable resource for clinicians and patients seeking to navigate the challenges of managing fatigue in ALS/MND, offering insights into current strategies and encouraging the development of new solutions.

Fatigue in ALS/MND: Navigating the Desert of a Debilitating Symptom

This review underscores the importance of addressing fatigue as a critical symptom in ALS/MND. The authors highlight the lack of established effective therapies and encourage further research into both pharmacological and non-pharmacological approaches to alleviate this debilitating symptom. This review serves as a valuable resource for clinicians and patients seeking to navigate the challenges of managing fatigue in ALS/MND, offering insights into current strategies and encouraging the development of new solutions.

Dr. Camel's Conclusion

The desert of ALS/MND fatigue is a challenging landscape, but researchers continue to seek new pathways to alleviate this debilitating symptom. This review highlights the need for further research and the importance of exploring both pharmacological and non-pharmacological approaches to improve the lives of individuals living with this challenging condition.

Date :
  1. Date Completed 2018-02-26
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

29293261

DOI: Digital Object Identifier

PMC6494184

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.